Orser Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,360
| Closed | -$220K | – | 88 |
|
|
2021
Q2 | $220K | Buy |
+1,360
| New | +$220K | 0.11% | 93 |
|
|
2021
Q1 | – | Sell |
-1,360
| Closed | -$208K | – | 87 |
|
|
2020
Q4 | $208K | Buy |
+1,360
| New | +$208K | 0.13% | 87 |
|
|
2018
Q3 | – | Sell |
-16,880
| Closed | -$1.1M | – | 87 |
|
|
2018
Q2 | $1.1M | Buy |
+16,880
| New | +$1.1M | 0.96% | 43 |
|